Leading research into ME/CFS

Company Name


We are delighted to announce that we have enrolled, seen and gathered samples from our target number of people with ME/CFS (both mild/moderate and severely affected). Meeting this goal has been made possible by those of you who volunteered to take part and put the word out to friends and family directly as well as via social media.

With your fantastic help we have over 500 people participating in the Biobank project – people with ME/CFS, Multiple Sclerosis and healthy controls – some of whom have donated blood samples twice.

As of November 2017 we have over 30,000 aliquots (samples) stored at the University College London/Royal Free Hospital BioBank, a state of the art facility, ready to be used for biomedical research.

On International ME Awareness Day (12th May 2016) we were delighted to be joined by some of you in London as we officially launched the UK ME/CFS Biobank. Since our opening we have distributed samples to researchers in the UK, Europe and America. We can’t thank you enough for your help.


UPDATE November 2017

CureME’s multi-year study into the biomarkers of ME/CFS has been renewed by the US National Institutes of Health for a further four years. This grant enables some further recruiting to the biobank, both to further our research at LSHTM and to provide samples for translational research at other institutions.

Recruiting for our Phase 2 study will be beginning in early 2018; to register your interest, please contact us.